NewsRx

Search our medical news database

Policy

Physician organizations urge Secretary Thompson to defend NIH review process

Published in Medical Letter on the CDC and FDA, December 7th, 2003

In light of growing controversy that has emerged over congressional scrutiny of certain grants funded by the U.S. National Institutes of Health (NIH), the Infectious Diseases Society of America (IDSA) and the HIV Medicine Association (HIVMA) sent a letter to U.S. Health and Human Services Secretary Tommy Thompson calling on him to support the public health value of research and to defend the integrity of the peer-review process that funds federal research grants.

While the level of government involvement remains unclear, more than 150 research grants on controversial but important public health issues, mainly dealing with HIV prevention and sexual behavior, have been...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook